KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Neogenomics (NEO) Inventory Average: 2009-2025

Historic Inventory Average for Neogenomics (NEO) over the last 15 years, with Sep 2025 value amounting to $31.3 million.

  • Neogenomics' Inventory Average rose 31.38% to $31.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.3 million, marking a year-over-year increase of 31.38%. This contributed to the annual value of $25.5 million for FY2024, which is 5.10% up from last year.
  • Neogenomics' Inventory Average amounted to $31.3 million in Q3 2025, which was down 2.05% from $32.0 million recorded in Q2 2025.
  • Over the past 5 years, Neogenomics' Inventory Average peaked at $32.0 million during Q2 2025, and registered a low of $21.4 million during Q2 2021.
  • In the last 3 years, Neogenomics' Inventory Average had a median value of $24.5 million in 2023 and averaged $25.7 million.
  • Its Inventory Average has fluctuated over the past 5 years, first decreased by 11.83% in 2024, then spiked by 46.88% in 2025.
  • Neogenomics' Inventory Average (Quarterly) stood at $22.6 million in 2021, then increased by 6.29% to $24.0 million in 2022, then climbed by 0.28% to $24.1 million in 2023, then rose by 6.21% to $25.6 million in 2024, then soared by 31.38% to $31.3 million in 2025.
  • Its Inventory Average stands at $31.3 million for Q3 2025, versus $32.0 million for Q2 2025 and $28.3 million for Q1 2025.